Zylox-Tonbridge

Hangzhou, China Founded: 2012 • Age: 14 yrs Listed
Medical equipment is manufactured by Zylox-Tonbridge in Hangzhou, China.

About Zylox-Tonbridge

Zylox-Tonbridge is a publicly listed company based in Hangzhou (China) founded in 2012. Medical equipment is manufactured by Zylox-Tonbridge in Hangzhou, China. Zylox-Tonbridge has completed 1 acquisition, including Optimed. Its chief executive, as recorded, is Zhong Zhao. Zylox-Tonbridge offers products and services including Neuro Vascular Devices and Patient Education Services. Its focus areas include Traditional Medical Devices. Its legal entity is ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Company details

Zylox-Tonbridge was established in 2012 and is based in Hangzhou, China. Operations focus on the production of medical equipment within the healthcare sector. Devices and tools are developed and assembled at facilities in China, serving regional and international markets. Leadership is provided by CEO Zhong Zhao, overseeing manufacturing and distribution activities.

  • Headquarters Hangzhou, China
  • Stage Public
  • Sectors
    Healthcare
  • Website zyloxtb.com
  • Social LinkedIn X Facebook
  • Legal Name Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Key Metrics
  • Annual Revenue
    $147.74 M (USD)
    35.18
    as on Dec 31, 2025
  • Net Profit
    $34.05 M (USD)
    143.81
    as on Dec 31, 2025
  • EBITDA
    $33.37 M (USD)
    136.71
    as on Dec 31, 2025
  • Investments & Acquisitions

Products & Services of Zylox-Tonbridge

Zylox-Tonbridge offers a comprehensive portfolio of products and services, including Neuro Vascular Devices and Patient Education Services.

Neuro Vascular Devices
Medical Devices

Revascularization devices are provided for neuro vascular applications to assist in patient care.

Patient Education Services
Information Services

Information about conditions and therapies is offered to patients and caregivers to enhance understanding.

People of Zylox-Tonbridge

1 people are tracked at Zylox-Tonbridge (1 in leadership).

NameRoleGroup
Zhong Zhao
CEOLeadership
Premium access

Complete people profiles for Zylox-Tonbridge

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Zylox-Tonbridge

Zylox-Tonbridge is a publicly listed company on the HKEX with ticker symbol 2190 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date05 Jul 2021
  • Listed onHKG: 2190
  • Listed entityZylox-Tonbridge Medical Technology Co., Ltd. Class H
  • Exchange sectorHealth technology
  • ISINCNE100004JD2
  • Share price21.00 HKD (-0.28% on the day) · 2026-10-14
  • Market capitalisation7,247,419,642.00 HKD
  • Price to earnings19.6
  • EPS (diluted, trailing year)1.07 HKD
  • Dividend yield1.24%
  • Volume (last session)265,000

Financials of Zylox-Tonbridge

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20251.15B HKD265.0M HKD259.7M HKD
2024848.4M HKD108.7M HKD109.7M HKD
2023583.2M HKD-87.0M HKD-131.2M HKD
2022388.5M HKD-132.1M HKD-238.1M HKD
2021214.4M HKD-240.7M HKD-236.7M HKD
Premium access

Detailed financial statements for Zylox-Tonbridge

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Zylox-Tonbridge

Zylox-Tonbridge has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Optimed.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Manufacturer of invasive therapy devices for vascular interventions, gastroenterology and urology
optimed.comEttlingen, Germany1996Jan 2026β€’β€’β€’β€’
Premium access

Complete acquisition details for Zylox-Tonbridge

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Zylox-Tonbridge

3 dated milestones of Zylox-Tonbridge across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Zylox-Tonbridge is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Optimed.

Web traffic of Zylox-Tonbridge

The website of Zylox-Tonbridge (zyloxtb.com) receives about 4.1K visits a month.

  • Monthly visits
    4.1K

    ▼ 25.2% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zylox-Tonbridge

Premium access

Complete news archive for Zylox-Tonbridge

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zylox-Tonbridge

Zylox-Tonbridge was founded in 2012.

Zylox-Tonbridge is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.

Zhong Zhao is the CEO of Zylox-Tonbridge, as recorded in our data.

Annual revenue of Zylox-Tonbridge is $147.74M as on Dec 31, 2025.

Zylox-Tonbridge was established in 2012 and is based in Hangzhou, China. Operations focus on the production of medical equipment within the healthcare sector. Devices and tools are developed and assembled at facilities in China, serving regional and international markets. Leadership is provided by CEO Zhong Zhao, overseeing manufacturing and distribution activities.

Zylox-Tonbridge offers Neuro Vascular Devices and Patient Education Services.

Yes, Zylox-Tonbridge is publicly traded on HKEX under the ticker symbol 2190.

Zylox-Tonbridge has made 1 acquisition, including Optimed.

Zylox-Tonbridge operates through Zylox-Tonbridge Medical Technology Co., Ltd..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available